Common MS Drug Causes Rare but Potentially Deadly Allergic Reactions, FDA Warns
The U.S. Food and Drug Administration (FDA) has added a so-called “black box” (“boxed warning”) alert to the multiple sclerosis drug Copaxone (glatiramer acetate) and its generic version, Glatopa, because…